Tuesday Concurrent Session Descriptions - 11:15 AM - 12:30 PM T207: After the Award - Re-budgeting and Cost Transfers
Central Administration, are you struggling with the quality of the re-budgeting requests sent by your departments? If you are new to approving re-budgeting requests do you know what level of detail you should expect? Department Administrators are you frustrated with Central Administration's delays in processing re-budgeting request, continual nitpicking about the justification. What is the difference between re-budgets and cost transfers? This session provides guidance on how to write better re-budgeting justifications and cost transfer explanations that are more likely to create less headache and be approved. Learn how to reduce the number of re-budgeting and cost transfers' requests. The session will also explore how organizations can structure institutional systems to reduce the number of re-budgets which are required. Certificate: FM-R / IRAM-IV Session Track: Financial and Post-award Administration Speakers: Kris Rhodes, Director, MAXIMUS, Olive Hill, KY
........................................................................................
T208: Internal & External Audit - What are We Seeing Today?
Research funding from sponsors requires all recipients to follow regulations, guidelines, sponsor rules and best practices. With these rules come audit findings from (historically) A-133 audits, direct cost audits, and sponsor priority areas for compliance reviews. In addition, research organizations are more often turning to their internal audit team to proactively review key risk areas. This session will discuss how to prepare for these respective audits, the audit methodology and how it differs between audit types, recent audit findings and corrective actions, and targeted areas where an organization can leverage internal audit. The speakers will also provide an opportunity for attendees to bring their own examples and questions relating to audits on our campuses. The session will be interactive and discussion is encouraged to provide guidance to all attendees. Certificate: FM-E Session Track: Sponsors and Agencies Speakers: Keith Graff, Grants Management Practice Leader, PwC, Chicago, IL; Kumar Mukesh, Director, Grants Management, University Hospitals Cleveland Medical Center, Cleveland, OH
........................................................................................
T209: Optimize Negotiation of Clinical Trial Agreements-Accelerated Clinical Trial Agreement
Tired of spending so much time and effort negotiating clinical trial agreements? Join us for the Accelerated Clinical Trials Agreement (ACTA) session to discover a rapidly growing initiative that can eliminate the need for negotiation of Industry Sponsored, Clinical Trial Agreements (CTAs) as well as a newly developed CTA for federal subcontracts. Commencing in August 2012, the Master Contracts Working Group consisted of 25 CTSA institutions collaborated with industry and the University Industry Demonstration Partnership to develop a standardized clinical trial agreement - a single agreement to be used (voluntarily) by each participating institution and sponsor, to reduce contract negotiations for industry sponsored multi-site studies Clinical Trials. The ACTA has been finalized with over 275 Institutions agreeing that the ACTA terms would be acceptable to their institution. The Federal Subcontracting CTA agreement has just been finalized and is about to begin rollout. Certificate: RL-III/ CTRA 101-E Session Track: Research Law Speakers: Terri Edwards, Associate Director, CTSA Coordinating Center, Nashville, Tennessee; Nickie Bruce, Director, Legal Contract Administration, Mayo Clinic, Rochester, MN; Libby Salberg, Director, Office of Contracts Management, Vanderbilt University Medical Center, Nashville, TN
........................................................................................
T210: Security and Tech Transfer Issues: A New Ballgame?
New cybersecurity requirements from NIST and DOD have substantial compliance implications for universities. Also completion of the Administration’s export control reform initiative has resulted in new control regimes while purporting to harmonize the regulations. What are the implications for your university? What strategies and resources are necessary to cope with the new requirements? How is your university coping? The tech transfer function at universities continues to evolve. Recent government initiatives have had a dual effect: In some cases they have decreased university rights in IP while increasing government control, while at the same time the government has been pushing for greater public access and open sourcing for research results. What does this mean for the existing tech transfer model based on the Bayh-Dole Act? What negotiating strategies are best? How can we also deal with IP issues in the growing activities with private foundations as well as issues such as F&A and indemnification? Session Track: RL-IV / PRAM-IV Speakers: Bob Hardy, Director, Contracts and Intellectual Property Management, Council on Governmental Relations, Washington, DC; Dave King, Associate University Counsel, University of Louisville, Louisville, KY
........................................................................................
.................................................................................................................................................................................................... ...................................................................................................................................................................................................
SRA INTERNATIONAL 2016 EXPLORE EDUCATE ENGAGE Online Program Book, NOT printed onsite